4//SEC Filing
Lipschultz Tyler 4
Accession 0001637761-23-000036
CIK 0001637761other
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 7:18 PM ET
Size
26.3 KB
Accession
0001637761-23-000036
Insider Transaction Report
Form 4
Lipschultz Tyler
SVP, Orthobiologics and BD
Transactions
- Disposition to Issuer
Common Stock
2023-01-05−131,284→ 0 total - Disposition to Issuer
Employee Stock Option (Right to Buy)
2023-01-05−60,000→ 0 totalExercise: $15.68Exp: 2025-08-01→ Common Stock (60,000 underlying) - Disposition to Issuer
Restricted Stock Units
2023-01-05−12,970→ 0 total→ Common Stock (12,970 underlying) - Disposition to Issuer
Restricted Stock Units
2023-01-05−33,977→ 0 totalExercise: $0.00→ Common Stock (33,977 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2023-01-05−35,636→ 0 totalExercise: $18.24Exp: 2027-01-01→ Common Stock (35,636 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2023-01-05−64,599→ 0 totalExercise: $14.19Exp: 2024-01-27→ Common Stock (64,599 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2023-01-05−6,089→ 0 totalExercise: $9.93Exp: 2028-04-23→ Common Stock (6,089 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2023-01-05−27,873→ 0 totalExercise: $12.01Exp: 2028-01-01→ Common Stock (27,873 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2023-01-05−16,196→ 0 totalExercise: $16.86Exp: 2029-01-28→ Common Stock (16,196 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2023-01-05−21,236→ 0 totalExercise: $15.00Exp: 2030-02-28→ Common Stock (21,236 underlying)
Footnotes (20)
- [F1]Disposed of pursuant to the Agreement and Plan of Merger by and among the issuer, SeaSpine Holdings Corporation, which became effective on January 5, 2023, in exchange for 54,653 Orthofix MedicalInc. ("Orthofix") ordinary shares having a market value of $22.76 per share at the effective time of the merger.
- [F10]This option was assumed by Orthofix in the merger and replaced with an option to purchase 26,892 shares of Orthofix at a price of $34.09 per share.
- [F11]The option vests as to 25% of the underlying shares on January 1, 2020 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
- [F12]This option was assumed by Orthofix in the merger and replaced with an option to purchase 14,835 shares of Orthofix at a price of $43.82 per share.
- [F13]The option vests as to 25% of the underlying shares on January 1, 2021 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
- [F14]This option was assumed by Orthofix in the merger and replaced with an option to purchase 11,603 shares of Orthofix at a price of $28.85 per share.
- [F15]The option fully vested and became exercisable on June 21, 2020.
- [F16]This option was assumed by Orthofix in the merger and replaced with an option to purchase 2,534 shares of Orthofix at a price of $23.86 per share.
- [F17]The option vests as to 25% of the underlying shares on January 28, 2022 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
- [F18]This option was assumed by Orthofix in the merger and replaced with an option to purchase 6,742 shares of Orthofix at a price of $40.50 per share.
- [F19]The option vests as to 25% of the underlying shares on February 28, 2023 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- [F20]This option was assumed by Orthofix in the merger and replaced with an option to purchase 8,840 shares of Orthofix at a price of $36.04 per share.
- [F3]The restricted stock units vest in three equal installments on each of January 28, 2022, 2023 and 2024.
- [F4]These restricted stock units were assumed by Orthofix in the merger and replaced by 5,399 Orthofix restricted stock units.
- [F5]The restricted stock units vest in three equal installments on each of February 28, 2023, 2024 and 2025.
- [F6]These restricted stock units were assumed by Orthofix in the merger and replaced by 14,144 Orthofix restricted stock units.
- [F7]The option vests as to 25% of the underlying shares on August 1, 2016 and the remaining 75% vests in twelve substantially equal quarterly installments thereafter.
- [F8]This option was assumed by Orthofix in the merger and replaced with an option to purchase 24,978 shares of Orthofix at a price of $37.67 per share.
- [F9]The option vests as to 12.5% of the underlying shares on August 1, 2016, 6.25% on September 30, 2016 and the remaining 81.25% vests in thirteen substantially equal quarterly installments thereafter.
Documents
Issuer
SeaSpine Holdings Corp
CIK 0001637761
Entity typeother
Related Parties
1- filerCIK 0001509284
Filing Metadata
- Form type
- 4
- Filed
- Jan 8, 7:00 PM ET
- Accepted
- Jan 9, 7:18 PM ET
- Size
- 26.3 KB